相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010-2019
Juliana Setyawan et al.
DRUG SAFETY (2021)
Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk
Ivan Ferraz-Amaro et al.
ARTHRITIS RESEARCH & THERAPY (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
Peter Willeit et al.
CIRCULATION (2020)
Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
Natalia Mena-Vazquez et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis
Christina Charles-Schoeman et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial
Benjamin Burggraaf et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Common atherosclerosis genetic risk factors and subclinical atherosclerosis in rheumatoid arthritis: the relevance of disease duration
Bartlomiej Kisiel et al.
RHEUMATOLOGY INTERNATIONAL (2019)
Atherosclerosis and inflammation: overview and updates
Glaucylara Reis Geovanini et al.
CLINICAL SCIENCE (2018)
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
R. Agca et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities
Aikaterini Arida et al.
RHEUMATOLOGY (2017)
Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study
Kensuke Kume et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation
Patricia Ruiz-Limon et al.
TRANSLATIONAL RESEARCH (2017)
Comparison of Carotid Plaque Score and Coronary Artery Calcium Score for Predicting Cardiovascular Disease Events: The Multi-Ethnic Study of Atherosclerosis
Adam D. Gepner et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
The Effects of Rituximab on Lipids, Arterial Stiffness, and Carotid Intima-Media Thickness in Rheumatoid Arthritis
Diana S. Novikova et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps
Thomas Zegkos et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2016)
Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis
Hyun-Je Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Serum Levels of Anticyclic Citrullinated Peptide Antibodies, Interleukin-6, Tumor Necrosis Factor-alpha, and C-Reactive Protein Are Associated with Increased Carotid Intima-Media Thickness: A Cross-Sectional Analysis of a Cohort of Rheumatoid Arthritis Patients without Cardiovascular Risk Factors
Monica Vazquez-Del Mercado et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis
Bartlomiej Kisiel et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions
Justin C. Mason et al.
EUROPEAN HEART JOURNAL (2015)
The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis-a randomized, placebo-controlled pilot trial
Lai-Shan Tam et al.
RHEUMATOLOGY (2014)
Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis?
Lai-Shan Tam et al.
RHEUMATOLOGY (2014)
Carotid Plaque Characteristics and Disease Activity in Rheumatoid Arthritis
Anne G. Semb et al.
JOURNAL OF RHEUMATOLOGY (2013)
Effect of intensive statin therapy on regression of carotid intima-media thickness in patients with subclinical carotid atherosclerosis (a prospective, randomized trial: PEACE (Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-lowering Therapy) study)
Koji Ikeda et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2013)
Effect of 1-Year Anti-TNF-α Therapy on Aortic Stiffness, Carotid Atherosclerosis, and Calprotectin in Inflammatory Arthropathies: A Controlled Study
Kristin Angel et al.
AMERICAN JOURNAL OF HYPERTENSION (2012)
NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis
Raquel Lopez-Mejias et al.
ATHEROSCLEROSIS (2012)
Mannheim Carotid Intima-Media Thickness and Plaque Consensus (2004-2006-2011) An Update on Behalf of the Advisory Board of the 3rd, 4th and 5th Watching the Risk Symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011
P. -J. Touboul et al.
CEREBROVASCULAR DISEASES (2012)
Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis
Kaisa M. Maeki-Petaejae et al.
CIRCULATION (2012)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment
Gorica G. Ristic et al.
RHEUMATOLOGY (2010)
Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?
T. E. Toms et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Association Between Anti-Cyclic Citrullinated Peptide Antibodies and Ischemic Heart Disease in Patients With Rheumatoid Arthritis
Francisco Javier Lopez-Longo et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis
M. van Leeuwen et al.
AUTOIMMUNITY REVIEWS (2009)
Rheumatoid Arthritis - A Model of Systemic Inflammation Driving Atherosclerosis
Ivy A. Ku et al.
CIRCULATION JOURNAL (2009)
Sustained improvement of vascular endothelial function during anti-TNF treatment in rheumatoid arthritis patients
P. I. Sidiropoulos et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2009)
Cytokines in atherosclerosis: Pathogenic and regulatory pathways
A Tedgui et al.
PHYSIOLOGICAL REVIEWS (2006)
Effect of anti-tumor necrosis factor α therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis
C Gonzalez-Juanatey et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s
N Goodson et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Rheumatoid arthritis: A disease associated with accelerated atherogenesis
MA Gonzalez-Gay et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Death rates and causes of death in patients with rheumatoid arthritis: a population-based study
S Sihvonen et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2004)
Explaining how high-grade systemic inflammation accelerates vascular risk in rheumatoid arthritis
N Sattar et al.
CIRCULATION (2003)
Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects
I del Rincón et al.
ARTHRITIS AND RHEUMATISM (2003)
Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease
C Gonzalez-Juanatey et al.
MEDICINE (2003)
Changes in plasma homocysteine in arthritis patients starting treatment with low-dose methotrexate subsequently supplemented with folic acid
O Slot
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2001)
Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques -: Longitudinal results from the aging vascular study (EVA) study
M Zureik et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity
RBM Landewé et al.
LANCET (2000)
分享论文
